Overview
Dr. George Ricaurte has a weekly clinic that focuses on Parkinsons disease and other movement disorders. In addition, he attends on the consult and in-patient neurology services at Johns Hopkins Bayview Medical Center. Dr. Ricaurte's research interests center on amphetamine-type stimulants and their potential to damage brain monoamine-containing neurons, including dopamine neurons (which degenerate in Parkinsons disease). Dr. Ricaurte and his colleagues are particularly interested in mechanisms of dopamine nerve cell degeneration. The long-term goal of this neurotoxicology research is to help find ways to prevent - or retard - the progression of Parkinsons disease and related neurodegenerative disorders. Dr. Ricaurtes work also has implications for the drug abuse field and substance abuse neuropsychiatric disorders. Dr. George Ricaurte received his medical degree from Northwestern University Medical School and his doctorate in Pharmacology from the University of Chicago. He then completed his residency in neurology at Stanford University Medical Center and did a one year fellowship at the Parkinsons Institute in California.
Dr. Ricaurte is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Essential Tremor.
His clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Neurotoxicity Syndromes.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Suite 1201, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David Cornblath is a Neurologist in Lutherville, Maryland. Dr. Cornblath is rated as an Elite provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.
Johns Hopkins Outpatient Center
Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy.
Johns Hopkins Bayview Medical Center
Dr. Peter Kaplan is Professor of Neurology and serves as the Director of Epilepsy and EEG at Johns Hopkins Bayview Medical Center. He focuses on epilepsy, clinical neurophysiology and nonconvulsive status epilepticus. He has written extensively about these subjects as well as about eclampsia and neurologic disease in women. Dr. Peter Kaplan received his medical training from St. Bartholomews Medical School, University of London. He then obtained membership to the Royal College of Physicians in England. He completed his residency in neurology at Duke University Medical Center. He completed fellowships in epilepsy and clinical neurophysiology at the same institution. Dr. Kaplan currently sees patients at the Johns Hopkins Bayview Medical Center on Tuesdays and Wednesdays. Dr. Kaplan is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Status Epilepticus, Epilepsy, and Awake Craniotomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Movement DisordersDr. Ricaurte isDistinguished. Learn about Movement Disorders.
- Parkinson's DiseaseDr. Ricaurte isDistinguished. Learn about Parkinson's Disease.
- Advanced
- ChoreaDr. Ricaurte isAdvanced. Learn about Chorea.
- Essential TremorDr. Ricaurte isAdvanced. Learn about Essential Tremor.
- Lewy Body Dementia (LBD)Dr. Ricaurte isAdvanced. Learn about Lewy Body Dementia (LBD).
- Primary Orthostatic TremorDr. Ricaurte isAdvanced. Learn about Primary Orthostatic Tremor.
- Secondary ParkinsonismDr. Ricaurte isAdvanced. Learn about Secondary Parkinsonism.
- Experienced
- Acute Cerebellar AtaxiaDr. Ricaurte isExperienced. Learn about Acute Cerebellar Ataxia.
- ApoplexyDr. Ricaurte isExperienced. Learn about Apoplexy.
- ApraxiaDr. Ricaurte isExperienced. Learn about Apraxia.
- Behr SyndromeDr. Ricaurte isExperienced. Learn about Behr Syndrome.
- Boucher-Neuhauser SyndromeDr. Ricaurte isExperienced. Learn about Boucher-Neuhauser Syndrome.
- CamptocormismDr. Ricaurte isExperienced. Learn about Camptocormism.